Showing 1,801 - 1,820 results of 3,189 for search '"vaccines"', query time: 0.09s Refine Results
  1. 1801

    Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma by Yujiao Zhou, Feifei Liu, Chengmin Li, Guo Shi, Xiaolei Xu, Xue Luo, Yuanling Zhang, Jingjie Fu, Aizhong Zeng, Limin Chen

    Published 2018-01-01
    “…Secondly, bone marrow-derived DCs were infected by Ad-AAH-IRES2-EGFP to yield AAH-DC vaccines. Matured DCs were demonstrated by increased expression of CD11c, CD80, and MHC-II costimulatory molecules. …”
    Get full text
    Article
  2. 1802

    COVID-19 workplace countermeasures that occupational physicians could not change in Japan: a qualitative study by Yu Igarashi, Seiichiro Tateishi, Juri Matsuoka, Tomoko Sawajima, Mika Kawasumi, Arisa Harada, Koji Mori

    Published 2025-01-01
    “…The responses were categorized into basic systems, occupational health services, workplace countermeasures, vaccines, and incidents, with a code count of 7, 8,147, 10, and 82, respectively. …”
    Get full text
    Article
  3. 1803

    Difficulties faced by physicians from four European countries in rebutting antivaccination arguments: a cross-sectional study by Fernanda Rodrigues, Cornelia Betsch, Pierre Verger, Harriet Fisher, Philipp Schmid, Dawn Holford, Angelo Fasce, Amanda Garrison, Linda Karlsson, Frederike Taubert, Stephan Lewandowsky, Anna Soveri

    Published 2024-07-01
    “…Introduction Physicians play a critical role in encouraging their patients to get vaccinated, in part by responding to patients’ concerns about vaccines. …”
    Get full text
    Article
  4. 1804

    Choosing the most suitable NGS technology to combine with a standardized viral enrichment protocol for obtaining complete avian orthoreovirus genomes from metagenomic samples by Sonsiray Álvarez-Narváez, Sonsiray Álvarez-Narváez, Telvin L. Harrell, Islam Nour, Sujit K. Mohanty, Steven J. Conrad

    Published 2025-02-01
    “…Currently available commercial vaccines are ineffective against new ARV variants and ARV outbreaks are increasing worldwide, requiring whole genome sequencing (WGS) to characterize strains that evade vaccines. …”
    Get full text
    Article
  5. 1805
  6. 1806

    Omicron: The rising fear for another wave in Malaysia by Lydia Ngiik-Shiew Law, Ke-Yan Loo, Joanna Xuan Hui Goh, Priyia Pusparajah

    Published 2021-12-01
    “…Pharmaceutical companies raced against the time to develop vaccines, believing that it would be sufficient to control COVID-19. …”
    Get full text
    Article
  7. 1807

    Diagnosis and Management of Bacterial Meningitis in the Paediatric Population: A Review by Catherine L. Tacon, Oliver Flower

    Published 2012-01-01
    “…Over recent decades new vaccines have led to a change in epidemiology of the disease; however, it remains a condition that requires a high index of suspicion, prompt diagnosis, and early management in the emergency department. …”
    Get full text
    Article
  8. 1808

    The effect of heat stress on humoral immnuity in broyler chickens by H. Hüseyin Hadimli, Kürşat Kav, Osman Erganiş

    “…The broilers were mucosally and orally vaccinated with ND and IB vaccines at 1 and 17 days, respectively. …”
    Get full text
    Article
  9. 1809

    EDITORIAL PAPER - MEDICAL TECHNIQUES by JT ADMIN

    Published 2019-12-01
    “…Health technology research could be in the form of procedures, vaccines, devices and systems as outlined by the world health organization in its Health technology assessment report. …”
    Get full text
    Article
  10. 1810

    The Involvement of Microglial Cells in Japanese Encephalitis Infections by Thananya Thongtan, Chutima Thepparit, Duncan R. Smith

    Published 2012-01-01
    “…Despite the availability of effective vaccines, Japanese encephalitis virus (JEV) infections remain a leading cause of encephalitis in many Asian countries. …”
    Get full text
    Article
  11. 1811

    Tailored Therapy in Lung Cancer by George Rakovich, Lise Tremblay

    Published 2013-01-01
    “…In addition, other related areas of active investigation, including tumour vaccines and pharmacogenetics, are briefly reviewed.…”
    Get full text
    Article
  12. 1812

    Immunisation schedule of the Pediatric Spanish Association: 2024 recommendations by Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, Elisa Garrote Llanos, Lucía López Granados, María Luisa Navarro Gómez, Valentín Pineda Solas, Irene Rivero Calle, Jesús Ruiz-Contreras, Ignacio Salamanca de la Cueva, Pepe Serrano Marchuet, Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, María Garcés-Sánchez, Elisa Garrote Llanos, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Valentín Pineda Solas, Irene Rivero Calle, Jesús Ruiz-Contreras, Pepe Serrano Marchuet

    Published 2025-01-01
    “…The AEP 2025 Vaccination and Immunization Schedule recommended for children, adolescents and pregnant women residing in Spain features the following novelties:Due to the increase in measles cases and outbreaks in recent years, we recommend advancing the second dose of measles, mumps and rubella (MMR) vaccine to 2 years of age.As a consequence of the above, since many autonomous communities (ACs) use the quadrivalent vaccine for the second dose of MMR and varicella vaccines, we recommend, for all ACs, advancing the second dose of varicella vaccine to 2 years of age.Due to the very significant increase in cases of pertussis since late 2023 and especially in 2024, we recommend advancing the dose of Tdap given in adolescence to 10–12 years of age.To complete protection against meningococcal disease in adolescence, we recommend vaccination against MenB at age 12 years.We believe that vaccination against seasonal influenza should be routine up to age 18 years, but given the disappointing coverage in children aged 6–59 months, we currently consider that improving this coverage should be prioritised, extending vaccination to children and adolescents aged 5–18 years once this objective has been achieved.Among other aspects, the routine immunization tables for healthy individuals and risk groups, the use of the new extended-valence conjugate vaccines against pneumococcal disease, routine vaccination at 4 months of age with MenACWY and vaccination against SARS-CoV-2 for individuals aged more than 6 months with risk factors remain unchanged with respect to the 2024 schedule. …”
    Get full text
    Article
  13. 1813

    Evaluation of IgG binding capability to SARS-CoV-2 variants in early COVID-19 convalescent sera using an indirect ELISA by Behzad Hussain, Peizhe Zhao, Yu Liu, Bo Yang, Xiaoxiong Li, Zhichao Zhang, Guoqiang Feng, Demei Zhang, Defen Lu, Wu Changxin

    Published 2025-02-01
    “…These results indicate that the patients recovering from natural infection of early original Wuhan strain may have the potential to resist infection of current circulating variants and the vaccines using the prototype antigen may still work for newly emerged variants.…”
    Get full text
    Article
  14. 1814

    Individual and community level maternal factors for zero-dose children in Ethiopia using mini-EDHS 2019: a mixed effects model by Anteneh Kassa Yalew, Werkneh Melkie Tilahun, Meron Asmamaw Alemayehu, Tigabu Kidie Tesfie, Muluken Chanie Agimas, Mekuriaw Nibret Aweke, Worku Necho Asferie, Moges Tadesse Abebe

    Published 2025-01-01
    “…Introduction Zero-dose children refer to a child who has not yet received any childhood vaccines. Globally, zero-dose children are the major public health problem. …”
    Get full text
    Article
  15. 1815

    The Mycoplasma hyopneumoniae protein Mhp274 elicits mucosal and systemic immune responses in mice by Mengqi Xie, Zhongshun Huang, Yun Zhang, Yujie Gan, Huiying Li, Dan Li, Honglei Ding

    Published 2025-02-01
    “…The bottleneck in the development of more effective vaccines for MPS is the stimulation of effective immune responses in the host. …”
    Get full text
    Article
  16. 1816

    Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy ro... by Jo Southern, Kennedy Otwombe, Eileen Dunne, Khuthadzo Hlongwane, Bradford D Gessner, Michelle Wong, Cheryl Cohen, Anne von Gottberg, Elizabeth Begier, Sharon Gray, Ebrahim Variava, Tumelo Moloantoa, Neil Martinson, Firdaus Nabeemeeah, Nadia Sabet, Lebohang M Mlambo, Phetho Mangena, Pattamukkil Abraham, Floris Swanepoel, Fahima Moosa, Mark Fletcher, Bha Ndungane-Tlakula, Jerusha Naidoo, Minja Milovanovic

    Published 2024-12-01
    “…Purpose In the setting of an established childhood pneumococcal vaccination programme with immediate initiation and treatment of antiretroviral therapy (ART) for people living with HIV (PLWH), the risk of adult pneumococcal community-acquired pneumonia (CAP) is not recently described. …”
    Get full text
    Article
  17. 1817
  18. 1818

    Roitt's essential immunology / by Delves, Peter J., Martin, Seamus J., 1966-, Burton, Dennis R., Roitt, Ivan M. (Ivan Maurice)

    Published 2017
    Table of Contents: “…Innate immunity -- Specific acquired immunity -- Antibodies -- Membrane receptors for antigen -- Antigen-specific recognition -- Immunological methods and applications [JS2] -- The anatomy of the immune response -- Lymphocyte activation -- The production of effectors -- The regulation of the immune response -- Development and evolution of the immune response -- Adversarial strategies during infection -- Vaccines -- Immunodeficiency -- Allergy and other hypersensitivities -- Transplantation -- Tumor immunology -- Autoimmune diseases.…”
    View in OPAC
    Electronic eBook
  19. 1819

    Transgenic Killer Commensal Bacteria as Mucosal Protectants by Luciano Polonelli

    Published 2001-01-01
    “…Unfortunately, current strategies for mucosal protection against candidiasis are severely limited by the lack of effective vaccines and the relative paucity and toxicity of commercially available antifungal drugs. …”
    Get full text
    Article
  20. 1820

    Beyond Borders: Understanding the Role of Drones in Healthcare Services in India and Abroad by Ankita Sharma, Bhavna Rani

    Published 2024-12-01
    “…Drones have the potential to be reliable medical delivery platforms for microbiological and laboratory samples, pharmaceuticals, vaccines, emergency medical equipment and patient transport. …”
    Get full text
    Article